Why is it important to document the BUD of a CSP?

Documenting the Beyond-Use Date (BUD) of a Compounded Sterile Preparation (CSP) is crucial primarily for ensuring proper use and patient safety. The BUD indicates the maximum date by which a CSP should be used to minimize the risk of contamination and instability. If a CSP is used beyond its BUD, there is the potential for diminished efficacy and increased risk of adverse reactions or infections due to the breakdown of the compound or microbial growth.

Accurate documentation of the BUD helps healthcare professionals manage the safe administration of medications, ensuring that patients receive treatments that are effective and safe. This practice aligns with the principles of quality assurance in sterile compounding, emphasizing the importance of patient care and safety in pharmacy operations. Thus, maintaining detailed records of the BUD is integral to effective patient management and medication therapy outcomes.